Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study-Reference-Cited by-同舟云学术

Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study

Published:2018-05-21 Issue:3 Volume:41 Page:244-254
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Shen Tian¹²,Wang Jiwei¹,Yu Yingjun³,Yu Jinming¹

Affiliation:

1. Department of Health Behavior and Health Education, Institute of Clinical Epidemiology, Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China

2. Department of Community Health and Behavioral Medicine, School of Public Health, Shanghai Jiao Tong University, Shanghai, China

3. Medical Affairs of Great China Region of Novartis, Beijing, China

Funder

This study was supported by grants from Novartis GCR.

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10641963.2018.1469640

Reference69 articles.

1. Heart Disease and Stroke Statistics—2009 Update